The Amogy–Lotte MoU: Real Signal, and Not a Stock You Can Own

On September 10, the Brooklyn startup Amogy and South Korea's Lotte Fine Chemical said they had signed a memorandum of understanding. The deal pairs two different halves of the ammonia economy: Amogy converts ammonia into hydrogen and then electricity, while Lotte Fine Chemical operates what the two companies describe as Asia's largest ammonia import, storage, and distribution network. The agreement targets three uses — green-hydrogen refueling stations, distributed power generation, and marine bunkering.

The part the headline leaves out matters more than what it states. Amogy is a private company. It has raised close to $300 million from venture and corporate backers and has not gone public. There is no Amogy ticker to buy and no public financial statement to read. The MoU is genuine commercial validation, but it is not something an ordinary U.S. retail investor can put in a portfolio today.

Nor, for that matter, is an MoU a strong financial anchor for anyone. It is a non-binding agreement to explore the three areas, and the specific projects remain to be determined following a business feasibility review. No order was booked and no revenue was recognized at the signing.

My preferred proof of an operating story — free cash flow — does not exist here, because Amogy is spending venture capital and reporting no public numbers. When that hard bridge is unavailable, the honest move is to say so and name the alternative evidence that would carry the case, with the uncertainty flagged. For Amogy, that anchor is contracts rather than memoranda. There is early, concrete progress: in June 2026 Amogy signed a supply agreement for a commercial-scale ammonia-to-power project in South Korea, and GS Engineering & Construction took a $15 million strategic stake in the company last November. Those are orders of a different rank than an MoU.

If you are tracking Amogy in hopes of a future listing, the number to watch is revenue from these commercial projects — and eventually cash flow that survives the venture stage. The company is targeting commercial operation of a distributed power project for the South Korean city of Pohang at up to 40 megawatts in 2028–2029. That is the kind of event that turns a technology story into a financial statement, and only then into something a public investor can judge on the numbers.

For an ordinary retail investor, the honest position right now is observer, not owner. The closest listed proxy would be a counterparty such as Lotte Fine Chemical, a public company in South Korea — but that is a different business with its own economics, not a way to own Amogy. The headline is worth reading as signal: Amogy is landing infrastructure partners that control a great deal of ammonia, which is how a young company earns credibility. It is not, by itself, an investment thesis with a number attached. When the proof point cannot be priced because there is no public statement and no cash flow, the disciplined answer is to hold your hands and wait for the MoU to become a contract, the contract to become revenue, and the revenue to show up where retail investors can actually see it.